A
0.026
0.00 (0.00%)
| Penutupan Terdahulu | 0.026 |
| Buka | 0.026 |
| Jumlah Dagangan | 3,043,638 |
| Purata Dagangan (3B) | 13,999,521 |
| Modal Pasaran | 76,570,000 |
| Harga / Buku (P/B) | 3.98 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Aug 2024 |
| Margin Keuntungan | -131.34% |
| Margin Operasi (TTM) | -17.76% |
| EPS Cair (TTM) | -0.010 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 132.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.62% |
| Nisbah Semasa (MRQ) | 13.91 |
| Aliran Tunai Operasi (OCF TTM) | -16.95 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -12.20 M |
| Pulangan Atas Aset (ROA TTM) | -45.37% |
| Pulangan Atas Ekuiti (ROE TTM) | -78.81% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (AU) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | ACTINOGEN FPO [ACW] | - | - |
AISkor Stockmoo
-0.5
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -1.0 |
| Purata | -0.50 |
|
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 15.36% |
| % Dimiliki oleh Institusi | 7.29% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |